- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06490575
Using Nonpharmacological Approaches in Hypertension Prevention and Management
The goal of this randomized controlled trial is to test the effectiveness of a four-module nutrition education resource promoting nonpharmacological approaches to prevent and manage hypertension. The main questions it aims to answer are:
- Does the educational intervention increase the knowledge of using nonpharmacological approaches in preventing and managing hypertension among participants?
- Does the educational intervention improve participants' lifestyle behaviors to prevent and manage hypertension? Researchers will compare a four-module educational intervention with a control group (no educational information received until after the study) to see if the educational intervention works to improve knowledge and healthy lifestyle behaviors in preventing and managing hypertension.
Participants will:
- Attend a 30-minute workshop every week for 4 weeks or no workshop at all
- Complete a survey on demographic information, knowledge, lifestyle behaviors, and quality of life at baseline and end of the study
- Complete a dietary 24-hour food recall at baseline, two weeks into the study, and at the end of the study
- Monitor blood pressure levels two times a day for four weeks
Study Overview
Status
Conditions
Detailed Description
Study Design:
This study is a randomized controlled trial with 30 participants randomly divided into control (n=15) and intervention (n=15) groups.
Pre- and post-survey Assessment:
All participants completed a comprehensive self-administered survey at baseline, which included:
- Knowledge related to hypertension and its management
- Lifestyle behaviors (diet, physical activity, alcohol intake, smoking status)
- Quality of life metrics
- Constructs from the Protection Motivation Theory (PMT), such as response efficacy, self-efficacy, perceived vulnerability, perceived severity, and intention
Dietary Assessment:
The Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) was used to assess participants' intake of fruits, vegetables, dietary sodium, and dietary potassium at three points:
- Baseline
- Mid-program (two weeks into the intervention)
- Post-intervention
Intervention:
The intervention group attended four weekly workshops, each lasting 30 minutes. The workshops were designed and led by a public health nutrition doctoral student and a nutrition expert. Each session included:
- Presentations with PowerPoint slides and interactive activities
- Group discussions
- Questions and answers
- Distribution of educational pamphlets and booklets
The educational sessions focused on:
- Increasing knowledge about hypertension prevention and management
- Promoting nonpharmacological approaches to prevent and manage hypertension, such as dietary changes and lifestyle modifications
- Addressing PMT components to influence participants' beliefs and intentions regarding their health behaviors
Control Group:
Participants in the control group did not receive any educational or counseling sessions during the intervention period. After the post-intervention survey, they were provided with all the educational materials and a brief overview of the contents.
Data Analysis:
Data collected from the surveys and ASA24 dietary assessments were analyzed using the Statistical Package for the Social Sciences (SPSS). Analyses focused on comparing changes in knowledge, lifestyle behaviors, quality of life, and dietary intake between the control and intervention groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kansas
-
Manhattan, Kansas, United States, 66502
- Justin Hall
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years old or older
- currently residing in Riley County, Kansas
- a US citizen or a permanent resident
- proficient in English
Exclusion Criteria:
- younger than 18 years old
- neither a US citizen nor a permanent resident
- nonproficient in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Participants in the control group received no educational or counseling sessions until the final post-survey questionnaires were administered.
|
|
|
Experimental: Nutrition Education
Participants in the intervention group attended four face-to-face educational workshops (one session per week).
|
Participants in the intervention group attended four face-to-face workshops (one session per week).
Each session took about 30 minutes and consisted of lectures with PowerPoint presentations, discussion, questions and answers, and the distribution of educational pamphlets and booklets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic and lifestyle pre- and post-survey instrument
Time Frame: 6 weeks
|
The survey includes items on knowledge, risk perceptions, assessment of response efficacy and self-efficacy, intention for behavior change, and lifestyle behaviors.
|
6 weeks
|
|
ASA24 automated self-administered 24-hour food recall
Time Frame: 6 weeks
|
This tool is based upon the validated Automated Multiple-Pass Method (AMPM) to collect dietary data using the 24-hour food recall.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
36-item quality of life
Time Frame: 6 weeks
|
The SF-36 includes one multi-item scale that assesses four major components: general health, mental health, physical health, and social function.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tandalayo Kidd, PhD, Kansas State University
Publications and helpful links
General Publications
- Chatzinikolaou A, Tzikas S, Lavdaniti M. Assessment of Quality of Life in Patients With Cardiovascular Disease Using the SF-36, MacNew, and EQ-5D-5L Questionnaires. Cureus. 2021 Sep 14;13(9):e17982. doi: 10.7759/cureus.17982. eCollection 2021 Sep.
- Carey RM, Whelton PK. The 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Resource for Practicing Clinicians. Ann Intern Med. 2018 Mar 6;168(5):359-360. doi: 10.7326/M18-0025. Epub 2018 Jan 23. No abstract available.
- Schapira MM, Fletcher KE, Hayes A, Eastwood D, Patterson L, Ertl K, Whittle J. The development and validation of the hypertension evaluation of lifestyle and management knowledge scale. J Clin Hypertens (Greenwich). 2012 Jul;14(7):461-6. doi: 10.1111/j.1751-7176.2012.00619.x. Epub 2012 Apr 9.
- Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ, Boehme AK, Buxton AE, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Fugar S, Generoso G, Heard DG, Hiremath S, Ho JE, Kalani R, Kazi DS, Ko D, Levine DA, Liu J, Ma J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Virani SS, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Martin SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25. Erratum In: Circulation. 2023 Feb 21;147(8):e622. doi: 10.1161/CIR.0000000000001137. Circulation. 2023 Jul 25;148(4):e4. doi: 10.1161/CIR.0000000000001167.
- Carey RM, Whelton PK; 2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018 Mar 6;168(5):351-358. doi: 10.7326/M17-3203. Epub 2018 Jan 23.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10334 (Other Identifier: CTEP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil